<?xml version="1.0"?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.0?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Eur J Histochem</journal-id>
      <journal-id journal-id-type="iso-abbrev">Eur J Histochem</journal-id>
      <journal-id journal-id-type="publisher-id">EJH</journal-id>
      <journal-title-group>
        <journal-title>European Journal of Histochemistry : EJH</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1121-760X</issn>
      <issn pub-type="epub">2038-8306</issn>
      <publisher>
        <publisher-name>PAGEPress Publications, Pavia, Italy</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmcid">4083322</article-id>
      <article-id pub-id-type="doi">10.4081/ejh.2014.2334</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Differential Expression Patterns of N-Acetylglucosaminyl Transferases and Polylactosamines in Uterine Lesions</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Clark</surname>
            <given-names>A.T.R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>da Costa</surname>
            <given-names>V.M.L. Guimar&#xE3;es</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>L. Bandeira</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cavalcanti</surname>
            <given-names>C.L. Bezerra</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>R&#xEA;go</surname>
            <given-names>M.J.B. de Melo</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Beltr&#xE3;o</surname>
            <given-names>E.I.C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <aff id="aff001"><label>1</label>Laborat&#xF3;rio de Imunopatologia Keizo Asami, <institution>Universidade Federal de Pernambuco</institution>, <addr-line>Recife, Brazil</addr-line></aff>
      <aff id="aff002"><label>2</label>N&#xFA;cleo para Inova&#xE7;&#xE3;o Terap&#xEA;utica, <institution>Universidade Federal de Pernambuco</institution>, <addr-line>Recife, Brazil</addr-line></aff>
      <aff id="aff003"><label>3</label>Departamento de Bioqu&#xED;mica, <institution>Universidade Federal de Pernambuco</institution>, <addr-line>Recife-PE, Brazil</addr-line></aff>
      <author-notes>
        <corresp id="cor1">Departamento de Bioqu&#xED;mica and Laborat&#xF3;rio de Imunopatologia Keizo Asami, Universidade Federal de Pernambuco, Recife-PE, 50670-901, Brazil. <phone>+55.81.21268484</phone> - <fax>+55.81.21268485</fax>. <email>ebeltrao@hotmail.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>5</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <day>15</day>
        <month>4</month>
        <year>2014</year>
      </pub-date>
      <volume>58</volume>
      <issue>2</issue>
      <elocation-id>2334</elocation-id>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>10</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>3</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;Copyright A.T.R. Clark et al.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Licensee PAGEPress, Italy</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<uri xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</uri>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Polylactosamine (polyLacNAc) is a fundamental structure in glycoconjugates and it is expressed in specific cells/tissues associated with the development and carcinogenesis. &#x3B2;1,3-<italic>N</italic>-acetylglucosaminyl transferases ((&#x3B2;3GnTs) play an important role in polyLacNAc synthesis, however the roles of these glycosyltransferases and their products in cancer progression are still unclear. In this sense, this work aimed to evaluate differential expression pattern of the N-acetylglucosaminyl transferases and polylactosamines in invasive and premalignant lesions of the uterus cervix. The expression of &#x3B2;3GnT2 and &#x3B2;3GnT3 were evaluated in normal (n=10) and uterine cervix lesions (n=120), both malignant [squamous carcinoma (SC)] and premalignant [cervical intraepithelial neoplasia (CIN), grades 1, 2 and 3] using immunohistochemistry. Besides, lectin histochemistry with <italic>Phytolacca americana</italic> lectin (PWM) and <italic>Wheat germ</italic> agglutinin (WGA) was also carried out to observe the presence of polyLacNAc chains and <italic>N-</italic>acetylglucosamine (GlcNAc), respectively. The &#x3B2;3GnT3 was expressed in almost all samples (99%) and &#x3B2;3GnT2 was higher expressed in disease samples mainly in CIN 3, when compared with normal (P=0.002), CIN 1 (P=0.009) and CIN 2 (P=0.03). The expression of polyLacNAc was higher is SC samples, when compared with normal (P=0.03), CIN 1 (P=0.02) and CIN 3 (P=0.004), and was observed only nuclear expression in nearly 50% of the SC samples, showing a statistically significant when compared with normal (P=0.01), CIN 1 (P=0.002), CIN 2 (P=0.007) and CIN 3 (P=0.04). Deferring from transferases and polyLacNAc chains, GlcNAc (WGA ligand) reveals a gradual staining pattern decrease with the increase of the lesion degree, being more expressed in CIN 1 lesions when compared with normal (P&lt;0.0001), CIN 2 (P&lt;0.0001), SC (P&lt;0.0001) and CIN 3 (P=0.0003). Our data reveal that &#x3B2;3GnT2 and polyLacNAc may be involved in the progression of the pre-malignant lesions of the human uterine cervix. In addition, polyLacNAc expression only in the nucleus can be associated a poor prognostic in uterine lesions.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>cancer</kwd>
        <kwd>lectin</kwd>
        <kwd>N-acetylglucosaminyl transferase</kwd>
        <kwd>poly-N-acetyllactosamine</kwd>
      </kwd-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="1"/>
        <equation-count count="0"/>
        <ref-count count="38"/>
        <page-count count="6"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-1">
      <title>Introduction</title>
      <p>Squamous carcinomas (SC) of the cervix usually is one of the most common malignancies in women worldwide<sup><xref rid="ref1" ref-type="bibr">1</xref></sup> and arises from metaplastic squamous mucosa in the region of the transformation zone;<sup><xref rid="ref2" ref-type="bibr">2</xref></sup> it is preceded by a long phase for pre-invasive disease, called CIN (cervical intraepithelial neoplasia).<sup><xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref3" ref-type="bibr">3</xref></sup> Traditionally, CIN are graded as CIN 1, CIN 2 and CIN 3, depending on the degree of differentiation.<sup><xref rid="ref3" ref-type="bibr">3</xref></sup> An accurate diagnosis of premalignant lesions is important to clinical management, but the histological diagnosis of CIN can be complicate.<sup><xref rid="ref3" ref-type="bibr">3</xref></sup> Studies of cell surface carbohydrates in these lesions are scarce and they can be useful for understanding the development of this type of lesion and its early diagnosis. Human cells are covered with a dense and complex array of glycoconjugates (glycoproteins, glycolipids and proteoglycans), that differs between cell types; for example, glycosylation of a single cell type significantly changes during cell development and differentiation.<sup><xref rid="ref4" ref-type="bibr">4-7</xref></sup></p>
      <p>Glycosylation is one of the most common post-translational modifications in eukaryotic cells.<sup><xref rid="ref8" ref-type="bibr">8-10</xref></sup> These glycosylated molecules are involved in a wide variety of biological events, such as cell activation,<sup><xref rid="ref11" ref-type="bibr">11</xref></sup> differentiation,<sup><xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref12" ref-type="bibr">12</xref></sup> infection,<sup><xref rid="ref13" ref-type="bibr">13</xref></sup> cell-cell, receptor-ligand, and carbohydrate-carbohydrate interactions.<sup><xref rid="ref4" ref-type="bibr">4</xref>,<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref15" ref-type="bibr">15</xref></sup> Furthermore, cell malignant transformations are often associated with structural alteration of carbohydrate chains in glycoconjugates,<sup><xref rid="ref5" ref-type="bibr">5-7</xref>,<xref rid="ref14" ref-type="bibr">14</xref></sup> and they may be directly or indirectly involved in cancer progression and malignancy.<sup><xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref14" ref-type="bibr">14</xref></sup> The polyLacNAc structure is a linear glycan containing repeats of the <italic>N</italic>-acetyllactosamine (LacNAc) unit (Gal&#x3B2;1-4GlcNA&#x3B2;1-3)<italic>n</italic>. It is a fundamental. structure of the carbohydrate chains in glycoproteins and glycolipids,<sup><xref rid="ref4" ref-type="bibr">4</xref>,<xref rid="ref16" ref-type="bibr">16</xref>,<xref rid="ref17" ref-type="bibr">17</xref></sup> being expressed in specific cells/tissues associated with development and cell-recognition, binding to several endogenous lectins.<sup><xref rid="ref16" ref-type="bibr">16</xref></sup> In cancer, polyLacNAc and related structures play important roles in cell-cell and cell-matrix interaction, determining metastatic capacity.<sup><xref rid="ref4" ref-type="bibr">4</xref>,<xref rid="ref17" ref-type="bibr">17</xref>,<xref rid="ref18" ref-type="bibr">18</xref></sup> Thus, the investigation of their presence may be useful for understanding the importance of polyLacNAc in cancer lesion.</p>
      <p>PolyLacNAc and GlcNAc can be identified in tissues <italic>by Phytolacca americana</italic> (PWM), lectin which binds with high affinity to polyLacNAc glycans bearing three or more linear <italic>N</italic>-acetyllactosamine repeats, and from <italic>Wheat germ</italic> agglutinin (WGA), respectively. Lectins have long been used as tools to characterize cell surface glycans because of their substantial selectivity in terms of branching, linkage and terminal modifications of complex glycans.<sup><xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref19" ref-type="bibr">19</xref></sup> The structure of these glycans depends on the glycosylation enzymes, glycosidases and glycosyltransferases, and the presence of appropriate sugar donors and receptors in the endoplasmic reticulum and Golgi apparatus of the eukaryotic cell,<sup><xref rid="ref8" ref-type="bibr">8</xref>,<xref rid="ref10" ref-type="bibr">10</xref>,<xref rid="ref16" ref-type="bibr">16</xref></sup> and they are very complex.<sup><xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref20" ref-type="bibr">20</xref></sup> A key enzyme in this process is &#x3B2;1,3-<italic>N</italic>-acetylglucosaminyl transferases (&#x3B2;3GnTs) that transfers an <italic>N</italic>-acetylglucosamine (GlcNAc) from UDP-GlcNAc to a galactose on the nonreducing end of the carbohydrate chain in a (&#x3B2;1,3-linkage.<sup><xref rid="ref15" ref-type="bibr">15</xref>,<xref rid="ref21" ref-type="bibr">21</xref>,<xref rid="ref22" ref-type="bibr">22</xref></sup> Eight &#x3B2;3GnTs, (&#x3B2;3GnT1 to (&#x3B2;3GnT8, have been isolated, and their <italic>in vitro</italic> activities have been characterized.<sup><xref rid="ref4" ref-type="bibr">4</xref></sup>,<sup><xref rid="ref15" ref-type="bibr">15-17</xref>,<xref rid="ref22" ref-type="bibr">22</xref>,<xref rid="ref24" ref-type="bibr">24</xref></sup> However, the roles of these multiple (&#x3B2;3GnTs on <italic>in vivo</italic> polylactosamine (polyLacNAc) synthesis are still unclear.</p>
      <p>This study aimed to investigate the expression of <italic>N</italic>-acetylglucosaminyl transferases (&#x3B2;3GnT2 and &#x3B2;3GnT3), the expression of polyLacNAc (one of their possible products), to evaluate the polyLacNAc structure in transformed uterine cervix tissues and visualize possible changes in the expression according to neoplasia grade.</p>
    </sec>
    <sec sec-type="materials|methods" id="sec1-2">
      <title>Materials and Methods</title>
      <sec id="sec2-1">
        <title>Materials</title>
        <p>Trypsin (T1005), streptavidin-peroxidase polymer (S2438), neuraminidase (N2133), horseradish peroxidase (P8375), lectin from <italic>Phytolacca americana</italic> (PWM) (L9379), <italic>Wheat germ</italic> agglutinin (WGA) biotin conjugated (L5141), <italic>N</italic>-acetyl-D-glucosamine (A8625) and antibodies included rabbit anti-B3GNT2 (HPA005897) and anti-B3GNT3 (HPA024298) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The visualization system, Advance&#x2122; HRP (K406889-2), and the chromogenic substrate (K346811-2), liquid diaminobenzidine (DAB) and substrate, were obtained from Dako (Glostrup, Denmark). Entellan&#xAE; (107960) was purchased from Merck (Whitehouse Station, NJ, USA).</p>
      </sec>
      <sec id="sec2-2">
        <title>Samples</title>
        <p>Malignant and premalignant lesions of uterine cervix were obtained from the Tissue Bank from Hospital das Cl&#xED;nicas at the Universidade Federal de Pernambuco, Northeast Brazil, after approval by the Health Science Ethical Committee from the same university (CEP/CCS/UFPE N&#xB0; 195/09). One hundred and thirty formalin-fixed and paraffin-embedded cases were collected and grouped according to their histopathological classification. In this sense, 120 samples of transformed tissues diagnosed as CIN grades 1 (n=30), 2 (n=30), 3 (n=30) and squamous carcinoma (SC, n=30). Ten samples of normal epithelium were also analyzed. Patients&#x2019; age at diagnosis time ranged between 23-83 year-old (mean 48.86&#xB1;14.78) to squamous-cell carcinoma; 24-89 year-old (mean 40.79&#xB1;14.93) to CIN 3; 25-89 year-old (mean 38.10&#xB1;15) to CIN 2 and 18-46 year-old (mean 33.08&#xB1;8.75) to CIN 1. Normal tissues samples were obtained from patients with 28-68 year-old age range (mean 40.77&#xB1;12.23).</p>
      </sec>
      <sec id="sec2-3">
        <title>Immunohistochemistry</title>
        <p>Tissue sections (4 &#xB5;m) were deparaffinized in xylene and hydrated in ethanol (100%-70%), treated with 10% (v/v) ammonium hydroxide solution for 10 min at 25&#xB0;C and with 10 mM citrate buffer pH 6.0 for 30 min at 100&#xB0;C on a steamer chamber.<sup><xref rid="ref25" ref-type="bibr">25</xref>,<xref rid="ref26" ref-type="bibr">26</xref></sup>. Afterwards, samples were treated with a 0.3% (v/v) H<sub>2</sub>O<sub>2</sub>-methanolsolution for 15 min at 25&#xB0;C, blocked with 1% (w/v) bovine serum albumin (BSA) solution in PBS (100 mM phosphate-buffered saline pH 7.2, containing 150 mM NaCl), for 1h at 25&#xB0;C. Thereafter, primary antibodies were diluted in 1% BSA-PBS (B3GnT2 1:50 and B3GnT3 1:100) and incubated for 2h at 37&#xB0;C. Incubation with Advance&#x2122; HRP link (Dako) was performed for 45 min, followed by Advance&#x2122; HRP Enzime (Dako) for 45 min both at 25&#xB0;C, as a biotin-free polymer method. Peroxidase reaction was revealed with 3,3&#x2019;-diaminobenzidine (Dako) and sections were counterstained with Harry&#x2019;s hematoxylin, dehydrated and mounted with Entellan&#xAE; (Merck). Between each step, samples were washed twice (5 min each) with PBS. Positive staining control was developed with gastrointestinal tract samples<sup><xref rid="ref22" ref-type="bibr">22</xref></sup> and negative ones by replacing the primary antibodies for blocking solution.</p>
      </sec>
      <sec id="sec2-4">
        <title>Lectin histochemistry</title>
        <p>After deparaffinination in xylene and hydration in ethanol (100%-70%), four micrometer thick tissues were treated with a 0.1% (w/v) trypsin solution for 2 min at 37&#xB0;C, followed by 100 mU/mL neuraminidase solution for 1 h at 37&#xB0;C and a 0.3% (v/v) H<sub>2</sub>O<sub>2</sub>-methanol solution for 15 min at 25&#xB0;C. PWM and WGA lectins incubations (20 &#xB5;g/mL) were carried out for 2 h at 4&#xB0;C. Biotynilated WGA lectin was visualized using streptavidin-peroxidase polymer (1:1000) for 45 min at 25&#xB0;C. PWM, a non-conjugated lectin, after tissue incubation were also incubated with a 5% (w/v) peroxidase solution for 1 h at 25&#xB0;C. Peroxidase was revealed with DAB according to de manufacturer&#x2019;s instructions. Sections were then counsterstained with Harry&#x2019;s hematoxylin, dehydrated in ethanol and mounted with Entellan&#xAE; (Merck). Between each step, samples were washed twice (5 min each) with 100 mM PBS solution pH 7.2, containing 150 mM NaCl. Inhibition of lectin-carbohydrate recognition (staining control) was developed by incubating tissues sections with lecting inhibited with their specific sugar (300 mM of <italic>N</italic>-acetyl-D-glucosamine for 30 min to WGA) prior to tissue incubation and negative staining control was developed by replacing lectins for PBS.</p>
      </sec>
      <sec id="sec2-5">
        <title>Staining analysis and image capture</title>
        <p>Image capture and analysis of tissues sections were carried out using a Nikon Eclipse 50i light microscope (USA) with a NIS-Elements F software (version 2.30). Random areas (&#xB5;m<sup><xref rid="ref2" ref-type="bibr">2</xref></sup>) were analyzed taking into account the number of stained cells per area. Staining intensity was measured according to Dornelas<sup><xref rid="ref27" ref-type="bibr">27</xref></sup> and Ferreira,<sup><xref rid="ref28" ref-type="bibr">28</xref></sup> as: 0, negative staining; 1+, low staining for up to 1/3 of cells stained; 2+, moderate staining for up to 2/3 of cells stained; and 3+, intense staining for more than 2/3 of cells stained. For statistical analysis we used a method where the results were dichotomized as high (3+ and 2+) or low (1+ and 0) expression.<sup><xref rid="ref29" ref-type="bibr">29</xref>,<xref rid="ref30" ref-type="bibr">30</xref></sup>.</p>
      </sec>
      <sec id="sec2-6">
        <title>Statistical analysis</title>
        <p>The Fischer&#x2019;s test was used to evaluate the relationship between positive staining and lesions grades. When P&lt;0.05 differences were considered significant. GraphPad Prism version 5.00 (GraphPad Software, Inc., La Jolla, CA, USA) statistical software was used for data analysis.</p>
      </sec>
    </sec>
    <sec id="sec1-3">
      <title>Results</title>
      <p>&#x3B2;3GnT3 showed to be expressed (<xref ref-type="fig" rid="fig001">Figure 1-1a</xref>) in the cytoplasm of 99% samples (<xref ref-type="table" rid="table001">Table 1</xref>). However, this expression was not different in among analyzed groups (<xref ref-type="fig" rid="fig002">Figure 2</xref>). &#x3B2;3GnT2 expression was observed in the cytoplasm (mainly in CIN 3 lesions) and it was higher than &#x3B2;3GnT3 (<xref ref-type="fig" rid="fig001">Figure 1-2a</xref> and <xref ref-type="table" rid="table001">Table 1</xref>) when compared with normal (P=0.002), CIN 1 (P=0.009) and CIN 2 (P=0.03) samples (<xref ref-type="fig" rid="fig002">Figure 2</xref>). The presence of GlcNAc terminal residues was also most commonly found in the cytoplasm and cell surface of CIN 1 lesions (<xref ref-type="fig" rid="fig001">Figure 1-3a</xref> and <xref ref-type="table" rid="table001">Table 1</xref>) when compared with normal (P&lt;0.0001), CIN 2 (P&lt;0.0001), SC (P&lt;0.0001) and CIN 3 (P=0.0003) samples (<xref ref-type="fig" rid="fig002">Figure 2</xref>). It was also observed a gradual expression decrease of this saccharide with the increasing degree of lesions (CIN 1, CIN 2, CIN 3, and SC), opposing to what was observed with the expression of both glycosyltransferases, &#x3B2;3GnT2 and &#x3B2;3GnT3 (<xref ref-type="fig" rid="fig002">Figure 2</xref>).</p>
      <p>PolyLacNAc chains, like GlcNAc terminal residues, were more expressed in cytoplasm and cell surface of lesion samples (<xref ref-type="fig" rid="fig001">Figure 1-4a</xref>). It was highly expressed in SC samples (<xref ref-type="table" rid="table001">Table 1</xref>), especially when compared with normal (P=0.03), CIN 1 (P=0.02) and CIN 2 (P=0.004) samples (<xref ref-type="fig" rid="fig002">Figure 2</xref>). In this sense, an increased expression of these saccharide chains was observed with an increased histologic degree of the lesion (<xref ref-type="fig" rid="fig002">Figure 2</xref>). For SC lesions nearly 50% of samples (<xref ref-type="table" rid="table001">Table 1</xref>) showed a polyLacNAc expression only in nucleus (<xref ref-type="fig" rid="fig003">Figure 3</xref>), whereas in premalignant lesions and normal samples this staining pattern was observed only in few cases (<xref ref-type="fig" rid="fig003">Figure 3</xref>) showing a statistically significant difference when compared with normal (P=0.01), CIN 1 (P=0.002), CIN 2 (P=0.007) and CIN 3 (P=0.04).</p>
    </sec>
    <sec id="sec1-4">
      <title>Discussion</title>
      <p>In 2001, Shiraishi <italic>et al.</italic><sup><xref rid="ref22" ref-type="bibr">22</xref></sup> demonstrated the expression of &#x3B2;3GnT2 in significant levels in many tissues, including uterus, while &#x3B2;3GnT3 was found but at lower levels. Togayachi and co-workers<sup><xref rid="ref21" ref-type="bibr">21</xref></sup> showed that &#x3B2;3GnT2 and &#x3B2;3GnT3 are considerably expressed in human cell lines of colon adenocarcinoma, lung squamous cell carcinoma, lung adenocarcinoma, stomach cancer, hepatoblastoma, prostatic cancer and pancreas cancer. Additionally, &#x3B2;3GnT2 was also significantly express in human leukemia and promyelocytic leukemia cell lines. Using immunohistochemistry our data also showed higher levels of &#x3B2;3GnT2 when compared with &#x3B2;3GnT3 in the normal uterine cervix. We also showed an expression of both glycosyltransferases in transformed human uterine cervix tissues, there are, however, higher levels of &#x3B2;3GnT2. Furthermore, our data demonstrate a progressive upregulation of &#x3B2;3GnT2 expression during the transformation progression of uterine cervix, maybe involved in essentials events in the establishing of the pre-malignant lesions. In transitional cell carcinoma of bladder, Gromova <italic>et al.</italic><sup><xref rid="ref14" ref-type="bibr">14</xref></sup> observed lower levels of &#x3B2;3GnT2 transcript in the invasive tumors, compared with their noninvasive counterparts, establishing a downregulation of &#x3B2;3GnT2 during bladder cancer progression. These findings show that glycosyltranferases play different roles according to the cell or tissue type involved. Tanaka <italic>et al.,</italic><sup><xref rid="ref31" ref-type="bibr">31</xref></sup> in nude mice, administered four cell lines in the abdominal cavities of the animals, where MKN45 (a human gastric cell line) was used to overexpress &#x3B2;-1,6-<italic>N-</italic>acetylglucosaminyl transferase, which led to an increased number of cell surface <italic>N</italic>-glycans containing polyLacNAc. They observed that the presence of larger polyLacNAc structures enhanced the metastatic potential of this tumor cell, when compared to the control cell lines.</p>
      <p>Several other studies have demonstrated the importance of polyLacNAc expression in the development and progression of many cancer types, as involved during differentiation,<sup><xref rid="ref32" ref-type="bibr">32</xref></sup> hyperproliferation,<sup><xref rid="ref33" ref-type="bibr">33</xref></sup> immune response<sup><xref rid="ref18" ref-type="bibr">18</xref></sup> and especially cancer growth and metastasis.<sup><xref rid="ref34" ref-type="bibr">34-37</xref></sup> In our results the polyLacNAc expression also demonstrated an involvement of this structure with the cancer process progression. We can also assign that the decreased expression of terminals residues of GlcNAc during the increasing of the lesion degree can been explained by the appearance of other carbohydrate antigens, such as Sialyl-Lewis A, Sialyl-Lewis X, Lewis Y and Thomsen-Friedenreich antigens, which may imply advantages for these cells and to the lesion progression process.<sup><xref rid="ref38" ref-type="bibr">38</xref></sup> Recently, Togayachi and co-workers<sup><xref rid="ref4" ref-type="bibr">4</xref></sup> have suggested that polyLacNAc chains on glycoproteins are synthesized mostly by &#x3B2;3GnT2 after observing a dramatically reduction in their expression in thymus, spleen, lymphocytes and macrophages of &#x3B2;3GnT2 knockout mice. They suggest that &#x3B2;3GnT2 is the major enzyme responsible for the synthesis of polyLacNAc chains on <italic>N</italic>-glycans <italic>in vivo.</italic> Another study<sup><xref rid="ref16" ref-type="bibr">16</xref></sup> also suggests that an increase in the activity of &#x3B2;3GnT2 increases polyLacNac chains in HL-60 cells, a human promyelocytic leukemia cells. This work showed a significant difference in the expression pattern of &#x3B2;3GnT2, GlcNAc and polyLacNAc chains among uterine lesions. &#x3B2;3GnT2 seems to be involved with the progression of the pre-malignant lesions, increasing their expression levels with the increasing of the grade of lesion and decreasing with the establishment of the malignant lesion. The opposite occurred with the GlcNAc expression; the expression decreased with the progression of pre-malignant lesions. PolyLacNAc chains expression showed to be progressive with the increasing of lesions grade but differently to &#x3B2;3GnT2 expression the former continues to increase until to the malignant lesion, being highly expressed in SC. When polyLacNAc is present only in the nucleus this feature was an indicative of poor prognosis. Its expression seems to be associated with the increase of the &#x3B2;3GnT2 during the progression of the pre-malignant lesions and may provide some advantages to tumor development such as differentiation, hyperproliferation, growth or metastasis.<sup><xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref14" ref-type="bibr">14</xref></sup> &#x3B2;3GnT2 and polyLacNAc expression can mediate pathophysiological key events during various stages of uterine lesions progression, including differentiation, hyperproliferation, growth and metastasis.<sup><xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref14" ref-type="bibr">14</xref></sup></p>
      <p>Our study was the first in the literature which aimed to analyze the expression of &#x3B2;3GnTs in uterine cervix and results showed the potential involvement of &#x3B2;3GnT2 and polyLacNAc chains in uterine lesions progression and to show that the nucleus expression of polyLacNAc chains can be associated to a poor prognostic in uterine lesions.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This work was financially supported by Conselho Nacional de Desenvolvimento Cient&#xED;fico e Tecnol&#xF3;gico (CNPq), Coordena&#xE7;&#xE3;o de Aperfei&#xE7;oamento de Pessoal de N&#xED;vel Superior (CAPES) and Funda&#xE7;&#xE3;o de Amparo &#xE0; Ci&#xEA;ncia e Tecnologia do Estado de Pernambuco (FACEPE).</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Protrka</surname><given-names>Z</given-names></name><name><surname>Arsenijevic</surname><given-names>S</given-names></name><name><surname>Dimitrijevic</surname><given-names>A</given-names></name><name><surname>Mitrovic</surname><given-names>S</given-names></name><name><surname>Stankovic</surname><given-names>V</given-names></name><name><surname>Milosavljevic</surname><given-names>M</given-names></name><etal/></person-group><article-title>Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions</article-title>. <source>Eur J Histochem</source><year>2011</year>;<volume>55</volume>:<fpage>e8</fpage><pub-id pub-id-type="pmid">21556123</pub-id></mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiltman</surname><given-names>AJ</given-names></name></person-group><article-title>The pathology of cervical tumours</article-title>. <source>Best Pract Res Cli Obstet Gynaecol</source><year>2005</year>;19:485-500.</mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>CM</given-names></name><name><surname>O'Leary</surname><given-names>JJ</given-names></name></person-group><article-title>Histology of cervical intraepithelial neoplasia and the role of biomarkers</article-title>. <source>Best Pract Res Cli Obstet Gynaecol</source><year>2011</year>;25:605-15.</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Togayachi</surname><given-names>A</given-names></name><name><surname>Kozono</surname><given-names>Y</given-names></name><name><surname>Ishida</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>N</given-names></name><name><surname>Tsunoda</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation</article-title>. <source>Proc Natl Acad Sci USA</source>,<year>2007</year>;104:15829-34.</mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>K</given-names></name><name><surname>Huh</surname><given-names>NH</given-names></name></person-group><article-title>A novel beta1,3-N-acetylglucosaminyl transferase involved in invasion of cancer cells as assayed in vitro</article-title>. <source>Biochemi Biophys Res Commun</source><year>2002</year>;<volume>294</volume>: <fpage>843</fpage>-<lpage>8</lpage></mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tateno</surname><given-names>H</given-names></name><name><surname>Uchiyama</surname><given-names>N</given-names></name><name><surname>Kuno</surname><given-names>A</given-names></name><name><surname>Togayachi</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Narimatsu</surname><given-names>H</given-names></name><etal/></person-group><article-title>A novel strategy for mammalian cell surface glycome profiling using lectin microarray</article-title>. <source>Glycobiology</source><year>2007</year>;<volume>17</volume>:<fpage>1138</fpage>-<lpage>46</lpage><pub-id pub-id-type="pmid">17693441</pub-id></mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couldrey</surname><given-names>C</given-names></name><name><surname>Green</surname><given-names>JE</given-names></name></person-group><article-title>Metastases: the glycan connection</article-title>. <source>Breast Cancer Res</source><year>2000</year>;<volume>2</volume>:<fpage>321</fpage>-<lpage>3</lpage><pub-id pub-id-type="pmid">11250723</pub-id></mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dojima</surname><given-names>T</given-names></name><name><surname>Nishina</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Uno</surname><given-names>T</given-names></name><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Kato</surname><given-names>K</given-names></name><etal/></person-group><article-title>Comparison of the N-linked glycosylation of human beta1, 3-N-acetylglucosaminyltransferase 2 expressed in insect cells and silkworm larvae</article-title>. <source>J Biotechnol</source><year>2009</year>;<volume>143</volume>:<fpage>27</fpage>-<lpage>33</lpage><pub-id pub-id-type="pmid">19540883</pub-id></mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>JG</given-names></name><name><surname>Ko</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name></person-group><article-title>Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer</article-title>. <source>BMB Rep</source><year>2011</year>;<volume>44</volume>:<fpage>765</fpage>-<lpage>71</lpage><pub-id pub-id-type="pmid">22189678</pub-id></mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Murata</surname><given-names>T</given-names></name><name><surname>Park</surname><given-names>EY</given-names></name></person-group><article-title>The effects of N-glycosylation sites and the N-terminal region on the biological function of beta1, 3-N-acetylglucosaminyltransferase 2 and its secretion</article-title>. <source>Biochem Biophys Res Commun</source><year>2005</year>;<volume>329</volume>:<fpage>699</fpage>-<lpage>705</lpage><pub-id pub-id-type="pmid">15737642</pub-id></mixed-citation>
      </ref>
      <ref id="ref11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demetriou</surname><given-names>M</given-names></name><name><surname>Granovsky</surname><given-names>M</given-names></name><name><surname>Quaggin</surname><given-names>S</given-names></name><name><surname>Dennis</surname><given-names>JW</given-names></name></person-group><article-title>Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation</article-title>. <source>Nature</source><year>2001</year>;<volume>409</volume>:<fpage>733</fpage>-<lpage>9</lpage><pub-id pub-id-type="pmid">11217864</pub-id></mixed-citation>
      </ref>
      <ref id="ref12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Yamakawa</surname><given-names>N</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Tojo</surname><given-names>H</given-names></name><name><surname>Tachi</surname><given-names>C</given-names></name><name><surname>Furukawa</surname><given-names>K</given-names></name></person-group><article-title>Differential gene expression of beta-1, 4-galactosyltransferases I, II and V during mouse brain development</article-title>. <source>J Neurochem</source><year>2001</year>;<volume>76</volume>:<fpage>29</fpage>-<lpage>38</lpage><pub-id pub-id-type="pmid">11145975</pub-id></mixed-citation>
      </ref>
      <ref id="ref13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teneberg</surname><given-names>S</given-names></name><name><surname>Leonardsson</surname><given-names>I</given-names></name><name><surname>Karlsson</surname><given-names>H</given-names></name><name><surname>Jovall</surname><given-names>PA</given-names></name><name><surname>Angstrom</surname><given-names>J</given-names></name><name><surname>Danielsson</surname><given-names>D</given-names></name><etal/></person-group><article-title>Lactotetraosylceramide, a novel glycosphingolipid receptor for Helicobacter pylori, present in human gastric epithelium</article-title>. <source>J Biol Chem</source><year>2002</year>;<volume>277</volume>:<fpage>19709</fpage>-<lpage>19</lpage><pub-id pub-id-type="pmid">11914375</pub-id></mixed-citation>
      </ref>
      <ref id="ref14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gromova</surname><given-names>I</given-names></name><name><surname>Gromov</surname><given-names>P</given-names></name><name><surname>Celis</surname><given-names>JE</given-names></name></person-group><article-title>A novel member of the glycosyltransferase family, beta 3 Gn-T2, highly downregulated in invasive human bladder transitional cell carcinomas</article-title>. <source>Mol Carcinog</source><year>2001</year>;<volume>32</volume>:<fpage>61</fpage>-<lpage>72</lpage><pub-id pub-id-type="pmid">11746818</pub-id></mixed-citation>
      </ref>
      <ref id="ref15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Togayachi</surname><given-names>A</given-names></name><name><surname>Kozono</surname><given-names>Y</given-names></name><name><surname>Kuno</surname><given-names>A</given-names></name><name><surname>Ohkura</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Hirabayashi</surname><given-names>J</given-names></name><etal/></person-group><article-title>Beta3GnT2 (B3GNT2), a major polylactosamine synthase: analysis of B3GNT2-deficient mice</article-title>. <source>Methods Enzymol</source><year>2010</year>;<volume>479</volume>:<fpage>185</fpage>-<lpage>204</lpage><pub-id pub-id-type="pmid">20816167</pub-id></mixed-citation>
      </ref>
      <ref id="ref16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seko</surname><given-names>A</given-names></name><name><surname>Yamashita</surname><given-names>K</given-names></name></person-group><article-title>Activation of beta1, 3-N-acetylglucosaminyltransferase-2 (beta3Gn-T2) by beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing poly-N-acetyllactosamine chains in differentiated HL-60 cells</article-title>. <source>J Biol Chem</source><year>2008</year>; <volume>283</volume> :<fpage>33094</fpage>-<lpage>100</lpage><pub-id pub-id-type="pmid">18826941</pub-id></mixed-citation>
      </ref>
      <ref id="ref17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>H</given-names></name><name><surname>Togayachi</surname><given-names>A</given-names></name><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Iwai</surname><given-names>T</given-names></name><name><surname>Hiruma</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><etal/></person-group><article-title>A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer</article-title>. <source>FEBS Lett</source><year>2005</year>;<volume>579</volume>:<fpage>71</fpage>-<lpage>8</lpage><pub-id pub-id-type="pmid">15620693</pub-id></mixed-citation>
      </ref>
      <ref id="ref18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuboi</surname><given-names>S</given-names></name><name><surname>Sutoh</surname><given-names>M</given-names></name><name><surname>Hatakeyama</surname><given-names>S</given-names></name><name><surname>Hiraoka</surname><given-names>N</given-names></name><name><surname>Habuchi</surname><given-names>T</given-names></name><name><surname>Horikawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans</article-title>. <source>EMBO J</source><year>2011</year>;<volume>30</volume>:<fpage>3173</fpage>-<lpage>85</lpage><pub-id pub-id-type="pmid">21712812</pub-id></mixed-citation>
      </ref>
      <ref id="ref19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>N</given-names></name><name><surname>Lis</surname><given-names>H</given-names></name></person-group><article-title>History of lectins: from hemagglutinins to biological recognition molecules</article-title>. <source>Glycobiology</source><year>2004</year>;<volume>14</volume>:<fpage>53R</fpage>-<lpage>62R</lpage></mixed-citation>
      </ref>
      <ref id="ref20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coutinho</surname><given-names>PM</given-names></name><name><surname>Deleury</surname><given-names>E</given-names></name><name><surname>Davies</surname><given-names>GJ</given-names></name><name><surname>Henrissat</surname><given-names>B</given-names></name></person-group><article-title>An evolving hierarchical family classification for glycosyltransferases</article-title>. <source>J Mol Biol</source><year>2003</year>;<volume>328</volume>:<fpage>307</fpage>-<lpage>17</lpage><pub-id pub-id-type="pmid">12691742</pub-id></mixed-citation>
      </ref>
      <ref id="ref21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Togayachi</surname><given-names>A</given-names></name><name><surname>Akashima</surname><given-names>T</given-names></name><name><surname>Ookubo</surname><given-names>R</given-names></name><name><surname>Kudo</surname><given-names>T</given-names></name><name><surname>Nishihara</surname><given-names>S</given-names></name><name><surname>Iwasaki</surname><given-names>H</given-names></name><etal/></person-group><article-title>Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide beta 1, 3-N-acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 Lewis X epitopes on glycolipids</article-title>. <source>J Biol Chem</source><year>2001</year>;<volume>276</volume>:<fpage>22032</fpage>-<lpage>40</lpage><pub-id pub-id-type="pmid">11283017</pub-id></mixed-citation>
      </ref>
      <ref id="ref22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiraishi</surname><given-names>N</given-names></name><name><surname>Natsume</surname><given-names>A</given-names></name><name><surname>Togayachi</surname><given-names>A</given-names></name><name><surname>Endo</surname><given-names>T</given-names></name><name><surname>Akashima</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Identification and characterization of three novel beta 1, 3-N-acetylglucosaminyltransferases structurally related to the beta 1, 3-galactosyltransferase family</article-title>. <source>J Biol Chem</source><year>2001</year>;<volume>276</volume>:<fpage>3498</fpage>-<lpage>507</lpage><pub-id pub-id-type="pmid">11042166</pub-id></mixed-citation>
      </ref>
      <ref id="ref23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narimatsu</surname><given-names>H</given-names></name></person-group><article-title>Human glycogene cloning: focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase families</article-title>. <source>Curr Opin Struct Biol</source><year>2006</year>;<volume>16</volume>:<fpage>567</fpage>-<lpage>75</lpage><pub-id pub-id-type="pmid">16979334</pub-id></mixed-citation>
      </ref>
      <ref id="ref24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Togayachi</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Narimatsu</surname><given-names>H</given-names></name></person-group><article-title>Comprehensive enzymatic characterization of glycosyltransferases with a beta3GT or beta4GT motif</article-title>. <source>Methods Enzymol</source><year>2006</year>;<volume>416</volume>:<fpage>91</fpage>-<lpage>102</lpage><pub-id pub-id-type="pmid">17113861</pub-id></mixed-citation>
      </ref>
      <ref id="ref25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedroso</surname><given-names>PMO</given-names></name><name><surname>Pescador</surname><given-names>CA</given-names></name><name><surname>Bandarra</surname><given-names>PM</given-names></name><name><surname>Raymundo</surname><given-names>DL</given-names></name><name><surname>Borba</surname><given-names>MR</given-names></name><name><surname>Wouters</surname><given-names>F</given-names></name><etal/></person-group><article-title>Standardization of immunohistochemistry technique for detection of rabies virus in formalin-fixed and paraffin-embedded tissue samples from central nervous system of cattle</article-title>. <source>Pesq Vet Bras.</source><year>2008</year>;<volume>28</volume>:<fpage>627</fpage>-<lpage>32</lpage></mixed-citation>
      </ref>
      <ref id="ref26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>FF</given-names></name><name><surname>Cruz</surname><given-names>MCFNd</given-names></name><name><surname>Pereira</surname><given-names>ALdA</given-names></name><name><surname>Silveira</surname><given-names>&#xC9;JDd</given-names></name><name><surname>Galv&#xE3;o</surname><given-names>HC</given-names></name><name><surname>Souza</surname><given-names>LBd</given-names></name><etal/></person-group><article-title>Immunohistochemical analysis of cytokeratins in ameloblastoma and adenomatoid odontogenic tumor</article-title>. <source>J Bras Patol Med Lab</source><year>2005</year>; <volume>41</volume> :<fpage>425</fpage>-<lpage>30</lpage></mixed-citation>
      </ref>
      <ref id="ref27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dornelas</surname><given-names>MT</given-names></name><name><surname>Rodrigues</surname><given-names>MF</given-names></name><name><surname>Machado</surname><given-names>DC</given-names></name><name><surname>Gollner</surname><given-names>AM</given-names></name><name><surname>Ferreira</surname><given-names>AP</given-names></name></person-group><article-title>Expression of cell proliferation and apoptosis biomarkers in skin spinocellular carcinoma and actinic keratosis</article-title>. <source>Na Bras Dermatol</source><year>2009</year>;<volume>84</volume>:<fpage>469</fpage>-<lpage>75</lpage></mixed-citation>
      </ref>
      <ref id="ref28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>SA</given-names></name><name><surname>Vasconcelos</surname><given-names>JL</given-names></name><name><surname>Silva</surname><given-names>RC</given-names></name><name><surname>Cavalcanti</surname><given-names>CL</given-names></name><name><surname>Bezerra</surname><given-names>CL</given-names></name><name><surname>Rego</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Expression patterns of alpha2,3-sialyltransferase I and alpha2,6-sialyltransferase I in human cutaneous epithelial lesions</article-title>. <source>Eur J Histochem</source><year>2013</year>;<volume>57</volume>:<fpage>e7</fpage><pub-id pub-id-type="pmid">23549466</pub-id></mixed-citation>
      </ref>
      <ref id="ref29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>dos Santos</surname><given-names>P</given-names></name><name><surname>Zanetti</surname><given-names>J</given-names></name><name><surname>Ribeiro-Silva</surname><given-names>A</given-names></name><name><surname>Beltrao</surname><given-names>E</given-names></name></person-group><article-title>Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study</article-title>. <source>Diagn Pathol</source><year>2012</year>;7:<fpage>104</fpage><pub-id pub-id-type="pmid">22894137</pub-id></mixed-citation>
      </ref>
      <ref id="ref30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petricevic</surname><given-names>B</given-names></name><name><surname>Vrbanec</surname><given-names>D</given-names></name><name><surname>Jakic-Razumovic</surname><given-names>J</given-names></name><name><surname>Brcic</surname><given-names>I</given-names></name><name><surname>Rabic</surname><given-names>D</given-names></name><name><surname>Badovinac</surname><given-names>T</given-names></name><etal/></person-group><article-title>Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer</article-title>. <source>Med Oncol</source><year>2012</year>;<volume>29</volume>:<fpage>486</fpage>-<lpage>94</lpage><pub-id pub-id-type="pmid">21400218</pub-id></mixed-citation>
      </ref>
      <ref id="ref31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Moriwaki</surname><given-names>K</given-names></name><name><surname>Yokoi</surname><given-names>S</given-names></name><name><surname>Koyama</surname><given-names>K</given-names></name><name><surname>Miyoshi</surname><given-names>E</given-names></name><name><surname>Fukase</surname><given-names>K</given-names></name></person-group><article-title>Whole-body imaging of tumor cells by azaelectrocyclization: visualization of metastasis dependence on glycan structure</article-title>. <source>Bioorg Med Chem</source><year>2013</year>; <volume>21</volume> :<fpage>1074</fpage>-<lpage>7</lpage><pub-id pub-id-type="pmid">23375093</pub-id></mixed-citation>
      </ref>
      <ref id="ref32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>SL</given-names></name><name><surname>Guo</surname><given-names>XH</given-names></name><name><surname>Shen</surname><given-names>HJ</given-names></name><name><surname>Zhang</surname><given-names>HP</given-names></name><name><surname>Chen</surname><given-names>HL</given-names></name></person-group><article-title>Expression of beta1, 3-N-acetylglucosaminyltransferases during differentiation of human acute myeloid leukemia cells</article-title>. <source>Mol Cell Biochem</source><year>2011</year>;<volume>358</volume>:<fpage>131</fpage>-<lpage>9</lpage><pub-id pub-id-type="pmid">21720768</pub-id></mixed-citation>
      </ref>
      <ref id="ref33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>A</given-names></name><name><surname>Terao</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>A</given-names></name><name><surname>Hanafusa</surname><given-names>T</given-names></name><name><surname>Murota</surname><given-names>H</given-names></name><name><surname>Katayama</surname><given-names>I</given-names></name><etal/></person-group><article-title>Upregulation of N-acetylglucosaminyltransferase-V by heparin-binding EGF-like growth factor induces keratinocyte proliferation and epidermal hyperplasia</article-title>. <source>Exp Dermatol</source><year>2012</year>; <volume>21</volume> :<fpage>515</fpage>-<lpage>9</lpage><pub-id pub-id-type="pmid">22716246</pub-id></mixed-citation>
      </ref>
      <ref id="ref34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>N</given-names></name><name><surname>Bane</surname><given-names>SM</given-names></name><name><surname>Ahire</surname><given-names>SD</given-names></name><name><surname>Ingle</surname><given-names>AD</given-names></name><name><surname>Kalraiya</surname><given-names>RD</given-names></name></person-group><article-title>Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3</article-title>. <source>Glycocon J</source><year>2009</year>;<volume>26</volume>:<fpage>445</fpage>-<lpage>56</lpage></mixed-citation>
      </ref>
      <ref id="ref35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>KS</given-names></name><name><surname>Dennis</surname><given-names>JW</given-names></name></person-group><article-title>N-Glycans in cancer progression</article-title>. <source>Glycobiology</source><year>2008</year>;<volume>18</volume>:<fpage>750</fpage>-<lpage>60</lpage><pub-id pub-id-type="pmid">18701722</pub-id></mixed-citation>
      </ref>
      <ref id="ref36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>JW</given-names></name><name><surname>Granovsky</surname><given-names>M</given-names></name><name><surname>Warren</surname><given-names>CE</given-names></name></person-group><article-title>Glycoprotein glycosylation and cancer progression</article-title>. <source>Biochim Biophys Acta</source><year>1999</year>; <volume>1473</volume> :<fpage>21</fpage>-<lpage>34</lpage><pub-id pub-id-type="pmid">10580127</pub-id></mixed-citation>
      </ref>
      <ref id="ref37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyoshi</surname><given-names>E</given-names></name><name><surname>Terao</surname><given-names>M</given-names></name><name><surname>Kamada</surname><given-names>Y</given-names></name></person-group><article-title>Physiological roles of N-acetylglucosaminyltransferase V(GnT-V) in mice</article-title>. <source>BMB Rep</source><year>2012</year>; <volume>45</volume> :<fpage>554</fpage>-<lpage>9</lpage><pub-id pub-id-type="pmid">23101508</pub-id></mixed-citation>
      </ref>
      <ref id="ref38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelstaedter</surname><given-names>V</given-names></name><name><surname>Fluegel</surname><given-names>B</given-names></name><name><surname>Kunze</surname><given-names>S</given-names></name><name><surname>Mayr</surname><given-names>D</given-names></name><name><surname>Friese</surname><given-names>K</given-names></name><name><surname>Jeschke</surname><given-names>U</given-names></name><etal/></person-group><article-title>Expression of the carbohydrate tumour marker Sialyl Lewis A, Sialyl Lewis X, Lewis Y and Thomsen-Friedenreich antigen in normal squamous epithelium of the uterine cervix, cervical dysplasia and cervical cancer</article-title>. <source>Histol Histopathol</source><year>2012</year>;<volume>27</volume>:<fpage>507</fpage>-<lpage>14</lpage><pub-id pub-id-type="pmid">22374728</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="fig001" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Immunohistochemistry and lectin histochemistry of premalignant and malignant lesions of human uterine cervix. 1a) Anti-&#x3B2;3GnT3 staining of cervical intraepithelial neoplasia grade 2, showing moderate dysplasia confined to the basal 2/3 of epithelium. 2a) Anti-&#x3B2;3GnT2 staining of invasive squamous carcinoma, showing staining of the invasive cells. 3a) <italic>Wheat germ</italic> agglutinin (WGA) staining squamous epithelium with cervical intraepithelial neoplasia grade 2. 4a) <italic>Phytolacca americana</italic> lectin (PWM) staining of cervical intraepithelial neoplasia grade 1. 1b, 2b, 3b, 4b) Negative controls for respective assay. 4c) <italic>Phytolacca americana</italic> lectin (PWM) staining of nucleus in invasive cells of squamous carcinoma.</p>
      </caption>
      <graphic xlink:href="ejh-2014-2-2334-g001"/>
    </fig>
    <fig id="fig002" orientation="portrait" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>Statistical analysis of anti-&#x3B2;3GnT2, anti-&#x3B2;3GnT3, <italic>Phytolacca americana</italic> lectin (PWM) and <italic>Wheat germ</italic> agglutinin (WGA) staining. *P&lt;0.05; **P&lt;0.005; ***P&lt;0.0005; CIN, cervical intraepithelial neoplasia; SC, squamous carcinoma.</p>
      </caption>
      <graphic xlink:href="ejh-2014-2-2334-g002"/>
    </fig>
    <fig id="fig003" orientation="portrait" position="float">
      <label>Figure 3.</label>
      <caption>
        <p>Statistical analysis of nuclear staining of <italic>Phytolacca americana</italic> lectin (PWM). *P&lt;0.05; **P&lt;0.005; ***P&lt;0.0005; CIN, cervical intraepithelial neoplasia; SC, squamous carcinoma.</p>
      </caption>
      <graphic xlink:href="ejh-2014-2-2334-g003"/>
    </fig>
    <table-wrap id="table001" orientation="portrait" position="float">
      <label>Table 1.</label>
      <caption>
        <p>Expression of &#x3B2;3GnT3, &#x3B2;3GnT2, GalNAc, PolyLacNAc and nuclear PolyLacNAc in normal, premalignant and malignant uterine lesions.</p>
      </caption>
      <table frame="box" rules="all">
        <thead>
          <tr>
            <th rowspan="1" colspan="1"/>
            <th align="center" colspan="2" rowspan="1">&#x3B2;3GnT3</th>
            <th align="center" colspan="2" rowspan="1">&#x3B2;3GnT2</th>
            <th align="center" colspan="2" rowspan="1">GalNAc</th>
            <th align="center" colspan="2" rowspan="1">PolyLacNAc</th>
            <th align="center" colspan="2" rowspan="1">Nuclear PolyLacNAc</th>
          </tr>
          <tr>
            <th rowspan="1" colspan="1"/>
            <th align="center" rowspan="1" colspan="1">Lower</th>
            <th align="center" rowspan="1" colspan="1">Higher</th>
            <th align="center" rowspan="1" colspan="1">Lower</th>
            <th align="center" rowspan="1" colspan="1">Higher</th>
            <th align="center" rowspan="1" colspan="1">Lower</th>
            <th align="center" rowspan="1" colspan="1">Higher</th>
            <th align="center" rowspan="1" colspan="1">Lower</th>
            <th align="center" rowspan="1" colspan="1">Higher</th>
            <th align="center" rowspan="1" colspan="1">Lower</th>
            <th align="center" rowspan="1" colspan="1">Higher</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" rowspan="1" colspan="1">Normal</td>
            <td align="center" rowspan="1" colspan="1">10</td>
            <td align="center" rowspan="1" colspan="1">0</td>
            <td align="center" rowspan="1" colspan="1">9</td>
            <td align="center" rowspan="1" colspan="1">1</td>
            <td align="center" rowspan="1" colspan="1">9</td>
            <td align="center" rowspan="1" colspan="1">1</td>
            <td align="center" rowspan="1" colspan="1">9</td>
            <td align="center" rowspan="1" colspan="1">1</td>
            <td align="center" rowspan="1" colspan="1">10</td>
            <td align="center" rowspan="1" colspan="1">0</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">CIN 1</td>
            <td align="center" rowspan="1" colspan="1">30</td>
            <td align="center" rowspan="1" colspan="1">0</td>
            <td align="center" rowspan="1" colspan="1">21</td>
            <td align="center" rowspan="1" colspan="1">9</td>
            <td align="center" rowspan="1" colspan="1">3</td>
            <td align="center" rowspan="1" colspan="1">27</td>
            <td align="center" rowspan="1" colspan="1">24</td>
            <td align="center" rowspan="1" colspan="1">6</td>
            <td align="center" rowspan="1" colspan="1">28</td>
            <td align="center" rowspan="1" colspan="1">2</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">CIN 2</td>
            <td align="center" rowspan="1" colspan="1">27</td>
            <td align="center" rowspan="1" colspan="1">3</td>
            <td align="center" rowspan="1" colspan="1">19</td>
            <td align="center" rowspan="1" colspan="1">11</td>
            <td align="center" rowspan="1" colspan="1">18</td>
            <td align="center" rowspan="1" colspan="1">12</td>
            <td align="center" rowspan="1" colspan="1">26</td>
            <td align="center" rowspan="1" colspan="1">4</td>
            <td align="center" rowspan="1" colspan="1">27</td>
            <td align="center" rowspan="1" colspan="1">3</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">CIN 3</td>
            <td align="center" rowspan="1" colspan="1">30</td>
            <td align="center" rowspan="1" colspan="1">0</td>
            <td align="center" rowspan="1" colspan="1">10</td>
            <td align="center" rowspan="1" colspan="1">20</td>
            <td align="center" rowspan="1" colspan="1">17</td>
            <td align="center" rowspan="1" colspan="1">13</td>
            <td align="center" rowspan="1" colspan="1">22</td>
            <td align="center" rowspan="1" colspan="1">8</td>
            <td align="center" rowspan="1" colspan="1">25</td>
            <td align="center" rowspan="1" colspan="1">5</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">SC</td>
            <td align="center" rowspan="1" colspan="1">30</td>
            <td align="center" rowspan="1" colspan="1">0</td>
            <td align="center" rowspan="1" colspan="1">16</td>
            <td align="center" rowspan="1" colspan="1">14</td>
            <td align="center" rowspan="1" colspan="1">23</td>
            <td align="center" rowspan="1" colspan="1">7</td>
            <td align="center" rowspan="1" colspan="1">15</td>
            <td align="center" rowspan="1" colspan="1">15</td>
            <td align="center" rowspan="1" colspan="1">17</td>
            <td align="center" rowspan="1" colspan="1">13</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>SC, squamous carcinoma; CIN, cervical intraepithelial neoplasia.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
